BEAM vs L · rev $63.5M vs P/E 14, rev $18.45B
Beam Therapeutics Inc (BEAM) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
BEAM currently screens at market cap $2.01B. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the BEAM and L stock pages for the full models.
Not investment advice.